Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638982 · ClinicalTrials.gov registry record · Phase 1
Axatilimab + CAR-T for High-Risk Lymphoma
A Phase 1 study, sponsored by Northside Hospital.
- Not yet
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT07638982 is a Phase 1 study that has not yet begun recruiting, run by Northside Hospital. The registered enrollment target is 29 participants.
The verdict
NCT07638982, a Phase 1 study, has not yet begun recruiting, sponsored by Northside Hospital.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
Axatilimab + CAR-T in High-Risk Lymphoma
Interventions
- DRUG Axatilimab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2026-10-31 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07638982
The ClinicalTrials.gov registry entry for NCT07638982 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northside Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Axatilimab is the first listed.
NCT07638982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07638982 about?
NCT07638982 is a clinical study titled "Axatilimab + CAR-T for High-Risk Lymphoma". Axatilimab + CAR-T in High-Risk Lymphoma
What is the current status of trial NCT07638982?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2026-10-31. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07638982?
The interventions under investigation include: Axatilimab (DRUG).
Who is sponsoring clinical trial NCT07638982?
This trial is sponsored by Northside Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.